<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00467129</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000540670</org_study_id>
    <secondary_id>SHEFF-SSREC01/271</secondary_id>
    <secondary_id>SHEFF-USMS-SSREC01/271</secondary_id>
    <secondary_id>EU-20727</secondary_id>
    <nct_id>NCT00467129</nct_id>
  </id_info>
  <brief_title>Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer</brief_title>
  <official_title>The Role of Genetic Factors in Clinical Outcome for Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sheffield</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Studying samples of blood and tumor tissue in the laboratory from patients with&#xD;
      cancer may help doctors learn more about changes that occur in DNA and help doctors&#xD;
      understand how patients respond to treatment.&#xD;
&#xD;
      PURPOSE: This clinical trial is examining genes that affect disease outcome in patients with&#xD;
      metastatic colorectal cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  Collect blood samples for DNA extraction for genetic studies from patients receiving&#xD;
           chemotherapy for metastatic colorectal cancer.&#xD;
&#xD;
        -  Collect detailed clinical, pathological, and chemotherapy data from these patients.&#xD;
&#xD;
        -  Identify genetic factors that relate to treatment response and outcome in these&#xD;
           patients.&#xD;
&#xD;
      OUTLINE: Blood samples are collected and relevant genes and regions are amplified by PCR. PCR&#xD;
      products are then sequenced or genotyped for known biological markers and single nucleotide&#xD;
      polymorphisms. Tumor samples from surplus pathology specimens are analyzed for expression of&#xD;
      candidate genes and mutation in the candidate genes.&#xD;
&#xD;
      Clinical and family history data is also collected by questionnaire.&#xD;
&#xD;
      PROJECTED ACCRUAL: A total of 800 patients will be accrued for this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2002</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Survival</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Progressive disease-free survival</measure>
  </primary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Colorectal Cancer</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>microarray analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>mutation analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>polymerase chain reaction</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>polymorphism analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>laboratory biomarker analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Diagnosis of metastatic colorectal cancer&#xD;
&#xD;
          -  Currently receiving chemotherapy at Weston Park Hospital&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
          -  Not Specified&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  See Disease Characteristics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela Cox, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Sheffield</affiliation>
  </overall_official>
  <verification_date>May 2007</verification_date>
  <study_first_submitted>April 25, 2007</study_first_submitted>
  <study_first_submitted_qc>April 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2007</study_first_posted>
  <last_update_submitted>December 17, 2013</last_update_submitted>
  <last_update_submitted_qc>December 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2013</last_update_posted>
  <keyword>stage IV colon cancer</keyword>
  <keyword>stage IV rectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

